It has been recently revealed in a report that the Food and Drug Administration has come up with an all new ‘biosimilar’ drugs. These drugs are actually much cheaper than the complex types usually available in the market. They are made from biological matter.

A latest report has unveiled that the Food and Drug Administration has voted against the wider use of Amgen Inc's drug Xgeva that is used for prevention of prostate cancer. It is being claimed by the FDA board that the benefits of Xgeva are not able to offset the risk of prostate cancer which could affect bones.

In a bid to make sure that there is no one infected with listeria, a Minnesota food company has ordered to call back over a million hard-cooked eggs from the market across 34 states. It was told that the eggs were produced at the company's plant in Wakefield, Neb., and from there, distributors bought the eggs. However, there are no reports as such of any human illness.

Making an important statement during the course of hearing at the district court on Wednesday, a U. S.

In a recent study, the Food and Drug Administration has given green signal to a drug which can cure cystic fibrosis. However, the drug, Kalydeco, from Vertex Pharmaceuticals Inc., would not be that easy to get as it may cost one to shell out as much as $294,000 a year.

It has been recently revealed in a report that the new drug developed by Amylin Pharmaceutical Company from San Diego has been given approval by the Food and Drug Administration in the U. S.

It has been further revealed that with the mere decision of the approval being out, the shares of the firm have seen a rise of 17% recently.

It has been recently revealed in a report that the new proposal of Amylin Pharmaceutical company for a more convenient and novel type of diabetes drug has been approved by the Food and Drug Administration.

As per recent reports, it has been revealed that Johnson & Johnson on Friday announced that it is willingly summoning up a lot of its Aveeno Baby Calming Comfort Lotion, as an assessment carried out recently by the US Food and Drug Administration (FDA) has revealed that it was containing more sorts of bacteria than permissible as per its tagged specifications.

Marking a grand success for the drugmaker Pfizer, its medicine Inlyta for patients suffering from advanced stages of kidney cancer has reportedly bagged a green light from the drug regulators in the United States, thereby marking a significant escalation in the efforts being made by the drug manufacturer with the intent of offsetting the sales of Lipitor.

It has been recently revealed that the drug for diabetes which was under trial by the FDA is not passed for authenticity for now. They are of the view that there is need for more research and data on the drug, before they can approve it. The name of the drug is dapagliflozin and the FDA is of the view that there is need to prove its worth according to safety, before it can be approved.